Novavax’s New York-listed shares shot up 14 per cent shortly after the market open on the news, stabilising at roughly 10 per cent higher. Crucially, the submission, Novavax said, included data …
https://www.ft.com/content/9615a666-0c99-4e65-98d0-027cb468aa3d